Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus paracasei VPro 224 and Reduced Salivary Levels of Mutans Streptococci

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 randomized controlled trials, all reported beneficial effects of Lactobacillus paracasei VPro 224 on reducing salivary mutans streptococci levels, with effect sizes ranging from moderate to large. The majority of studies were conducted in children (3 of 4). No specific dose or form was consistently reported.

  • Studied populations: Children (preschool and school-age); one study in healthy adults (20–26 years)

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). No dose or form data were reported, and study durations were not consistently recorded, limiting the ability to determine optimal usage.

Generated Jul 11, 2026
4 of 4 papers
Back to top